Aprea Therapeutics, Inc.

( )
APRE After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 0.06%34.530.9%$1198.50m
JNJJohnson & Johnson 1.45%143.010.7%$1128.83m
BMYBristol-Myers Squibb Co. 1.79%60.201.0%$994.54m
MRKMerck & Co., Inc. 0.98%79.550.7%$857.47m
ABBVAbbVie, Inc. 0.14%99.021.9%$812.27m
LLYEli Lilly & Co. 1.89%166.961.1%$712.27m
AZNAstraZeneca Plc 0.56%54.101.2%$302.78m
RPRXRoyalty Pharma Plc 0.83%46.110.1%$254.77m
VXRTVaxart, Inc. -12.62%6.440.0%$196.21m
NVSNovartis AG 1.03%88.470.2%$162.04m
GSKGlaxoSmithKline Plc -0.51%41.010.2%$121.91m
RGENRepligen Corp. -0.05%126.597.2%$120.09m
NVONovo Nordisk A/S -0.65%65.930.1%$94.22m
RETAReata Pharmaceuticals, Inc. 1.63%160.433.4%$89.15m
SNYSanofi 1.12%52.200.2%$81.02m

Company Profile

Aprea Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wenji Bao in 2002 and is headquartered in Boston, MA.